[Clinical trial of protease inhibitor in the treatment of fulminant hepatitis].
Yasunaga
M
M
First Department of Internal Medicine, Yamaguchi University School of Medicine.
Mori
K
K
Yamashita
S
S
Okita
K
K
D000818:Animals; D000990:Antithrombin III / Q000627:therapeutic use*; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy / Q000209:etiology; D016670:Gabexate / Q000627:therapeutic use*; D006505:Hepatitis / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D011480:Protease Inhibitors / Q000627:therapeutic use*
D011480:Protease Inhibitors; D016670:Gabexate; D000990:Antithrombin III